Oxbow Advisors’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.5M Buy
152,059
+9,078
+6% +$647K 0.98% 21
2025
Q4
$8.82M Buy
142,981
+37,246
+35% +$2.19M 0.78% 28
2025
Q3
$6.21M Buy
105,735
+781
+0.7% +$45.5K 0.58% 44
2025
Q2
$6.11M Sell
104,954
-19,079
-15% -$1.08M 0.67% 44
2025
Q1
$6.16M Buy
124,033
+3,949
+3% +$202K 0.65% 39
2024
Q4
$5.37M Buy
120,084
+634
+0.5% +$30.1K 0.63% 40
2024
Q3
$5.74M Buy
119,450
+48,645
+69% +$2.34M 0.57% 44
2024
Q2
$3.6M Buy
70,805
+1,256
+2% +$68.8K 0.42% 56
2024
Q1
$3.78M Buy
+69,549
New +$3.63M 0.52% 50
2023
Q2
Sell
-6,033
Closed -$446K 214
2023
Q1
$446K Buy
6,033
+233
+4% +$18K 0.08% 133
2022
Q4
$424K Buy
+5,800
New +$458K 0.08% 143
2022
Q3
Sell
-98,639
Closed -$7.86M 251
2022
Q2
$7.86M Buy
98,639
+1,248
+1% +$121K 1.12% 28
2022
Q1
$10.1M Sell
97,391
-54,390
-36% -$4.51M 1.02% 32
2021
Q4
$11.4M Sell
151,781
-2,672
-2% -$187K 1.09% 32
2021
Q3
$10M Buy
154,453
+47,050
+44% +$2.88M 1.02% 33
2021
Q2
$6.51M Buy
+107,403
New +$6.35M 0.68% 54

Other funds holding NTR

Oxbow Advisors's NTR Position: Q1 2026 in Review

Oxbow Advisors increased its Nutrien (NTR) stake by 6.3% in Q1 2026, buying an estimated $647K and bringing the position to 152,059 shares worth $11.5M. The position accounts for 0.98% of the portfolio, ranked #21.

Oxbow Advisors first reported a position in NTR in Q2 2021 and has held it in 16 quarters since. 747 funds tracked by Wall St. Rank hold NTR as of Q1 2026.

  • Oxbow Advisors held 152,059 shares of Nutrien worth $11.5M as of Q1 2026.
  • Oxbow Advisors bought 9,078 Nutrien shares in Q1 2026, an estimated $647K.
  • Nutrien made up 0.98% of Oxbow Advisors's portfolio in Q1 2026, its #21 holding.
  • Oxbow Advisors first reported a position in Nutrien in Q2 2021 and has held it in 16 quarters since.
  • 747 funds tracked by Wall St. Rank held Nutrien as of Q1 2026.

Based on Oxbow Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.